Stay updated on SBRT ± Nivolumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the SBRT ± Nivolumab in NSCLC Clinical Trial page.

Latest updates to the SBRT ± Nivolumab in NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedLocations section added listing Texas sites (Conroe, The Woodlands, Houston, and West Houston MD Anderson campuses); HHS Vulnerability Disclosure and Texas Locations were removed, and the revision updated to v3.3.3.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check42 days agoChange DetectedPublications section now notes that publications are automatically filled from PubMed. The page revision has been updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check49 days agoChange DetectedRemoved the government funding/operating status notice from the page. No other content changes are evident.SummaryDifference0.4%

- Check56 days agoChange DetectedDate-related metadata in the Study Record Dates was updated with new entries (2025-11-03 and 2025-10-31) and an 'Last Update Posted (Estimated)' label; older entries such as 'Last Update Posted' and dates from 2025-04/2025-05 were removed.SummaryDifference0.3%

- Check63 days agoChange DetectedNo significant changes to core study details were detected; changes appear cosmetic or administrative, not affecting the study's purpose or patient eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check92 days agoChange Detected- Added a prominent notice about potential outages due to lapse in government funding and updated operating status guidance. - Updated version from v3.1.0 to v3.2.0.SummaryDifference2%

Stay in the know with updates to SBRT ± Nivolumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SBRT ± Nivolumab in NSCLC Clinical Trial page.